ANRO three-lens brief
Evidence-based stock research on ANRO. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price down 7.01% in the last session — a material single-day move. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Price down 7.01% in the last session — a material single-day move.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Outperforming SPY by 14.7pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $38.38 — 21% above current (10 analysts).
ANRO closed at $31.68 (-7.01%) as of 2026-09-11. Market cap: $1.24B. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; outperforming SPY by 14.7pp over 30 days.. Concerns: price down 7.01% in the last session — a material single-day move.; currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: net income -$27.64M, free cash flow -$42.90M.
Why three lenses on ANRO, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ANROacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ANRO" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ANRO brief"></iframe>